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L-arginine decreases the infiltration of the kidney by
macrophages in obstructive nephropathy and
puromycin-induced nephrosis
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Renal Division and Department of Medicine, Washington University School of Medicine and the Jewish Hospital of St. Louis, St. Louis,
Missouri and Department of Pediatrics, Maimonides Medical Center, Brooklyn, New York, USA
L-argirnne decreasses the infiltration of the kidney by macrophages in
obstructive nephropathy and puromycin-induced nephrosis. We exam-
ined the effect of 1% L-arginine in the drinking water on the infiltration
of the kidney by macrophages in rats with puromycin aminonucleoside-
induced nephrosis (PAN) and in rats with bilateral ureteral obstruction
(BUO) of 24 hours duration. Rats given L-arginine in the drinking water
for three days before BUO or PAN was initiated had a greater
glomerular filtration rate after release of BUO or induction of PAN than
similar rats not given L-arginine (P < 0.0001). Administration of
L-arginine decreased the renal infiltration by macrophages in rats with
PAN (P < 0.0001) or BUO (P < 0.0001) compared to rats with PAN or
BUO given tap water alone. Chemotaxis studies suggested that macro-
phages were activated during obstruction as evidenced by the greater
random migration of peritoneal macrophages obtained from rats with
24-hour urethral obstruction than from sham-operated rats (SOR; P <
0.0001). In vitro, maximal chemotaxis induced by 7% zymosan-acti-
vated serum (ZAS) in peritoneal macrophages from SOR was enhanced
by low (10—6 to iO M) and decreased by high concentrations (10 to
10—2 si) of L-arginine in the incubation medium. Migration of macro-
phages from rats with urethral obstruction was increased by 7% ZAS
but the increase diminished with high concentrations of L-arginine
(l0 to 10_2 M). Random migration of peritoneal macrophages ob-
tained from rats with urethral obstruction given L-arginine prior to
obstruction was significantly lower than that of peritoneal macrophages
obtained from similar rats given tap water alone prior to obstruction.
Plasma levels of corticosterone were greater (P < 0.002) in rats with
BOO given L-arginine than in rats with BUO given tap water alone.
Thus, administration of L-arginine improves renal function of rats with
PAN or BUO. This may be due, at least in part, to decreased renal
macrophage infiltration. L-arginine may cause this decrease in macro-
phage infiltration by directly inhibiting macrophage chemotaxis and by
increasing the levels of circulating corticosterone.
Oral administration of L-arginine improves renal function in
rats with unilateral release of bilateral ureteral obstruction
(BUO) [1], subtotal nephrectomy [2], experimental diabetes
mellitus [31 and salt-sensitive hypertension [4]. L-arginine also
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has beneficial effects on hypercholesterolemia [5] and wound
healing [6—8]. However, the mechanism(s) underlying the effect
of L-arginine on renal function are still unclear due, at least in
part, to the different metabolic pathways of L-arginine in vivo.
L-arginine plays a key role in the synthesis of urea [9],
creatinine [10] and nitric oxide [11]. In addition, it interacts with
glucagon, insulin and growth hormone [12, 13]. The several
metabolic pathways in which L-arginine is involved may all
contribute to the effect(s) of oral administration of L-arginine on
renal and extrarenal physiology and pathophysiology.
Infiltration of the renal parenchyma by macrophages in rats
with BUO of 24 hours duration and in rats given the aminonu-
cleoside of puromycin is associated with decreased renal func-
tion. Although the kinetics of this infiltration are markedly
different in these two models of renal disease, infiltration of the
kidney by macrophages may account for many of the alterations
in renal function observed in these rats [14]. The experimental
maneuvers presently available to decrease or prevent the
infiltration of the renal parenchyma by macrophages all are
fraught with side effects. These maneuvers include: total body
irradiation [15, 16], silica administration [17], and administra-
tion of steroids and a variety of cytotoxic and cytostatic agents
[18]. The ideal agent should decrease infiltration of the kidney
by macrophages without inducing systemic immunosuppression
and should be devoid of the side effects of the therapies
currently available. Such an agent would be useful in amelio-
rating or preventing the decrease in renal function seen in
cell-mediated diseases of the kidney.
To gain further insight into the mechanism(s) governing the
interactions of L-arginine with macrophages we examined the
effects of L-arginine on macrophage migration into the kidney
in rats with two unrelated models of renal disease characterized
by macrophage infiltration. In addition, we studied the effects of
L-arginine in vitro on the chemotaxis of pentoneal macro-
phages. We found that L-arginine administration improves
renal function and ameliorates the infiltration of the renal
parenchyma by macrophages in these two models of renal
disease. L-arginine, in concentrations similar to those in normal
renal tissue, inhibits in vitro the chemotaxis of pentoneal
macrophages obtained from normal rats or rats with obstructive
uropathy.
Methods
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Clearance studies
Animals
Female Sprague-Dawley rats (N = 120); (Harlan, Indianapo-
lis, Indiana, USA) weighing 200 to 270 g were fed a standard rat
chow containing 22.8% protein and 1.42% L-arginine (Ralston
Purina, Saint Louis, Missouri, USA). The remaining 21.38% of
the protein in this rat chow is made up by a balanced mixture of
other essential and non-essential amino acids. The rats were
allowed tap water ad libitum. Studies were performed at least
seven days after arrival of the rats at our animal care facility.
Rats undergoing obstruction of the urinary tract had no access
to water after the procedure and were studied 24 hours later.
Some animals were given 1% L-arginine in the drinking water
for various intervals of time, as noted in the Results.
Surgical procedures
Bilateral ureteral obstruction (BUO, N = 20) or sham oper-
ation (N 30) was performed as previously described [191.
Briefly, rats under light anesthesia with halothane (Ayerst
Laboratories Inc., Philadelphia, Pennsylvania, USA) had both
ureters ligated at the junction of the lower one third and the
upper two thirds through a small suprapubic abdominal inci-
sion. Sham-operated rats (SOR) had both ureters manipulated
but not ligated. After surgery rats were returned to their cages.
Both groups of rats were fasted for the next 24 hours. Water
was withheld from rats with BUO but not from SOR. For the
chemotactic studies described below, urethral obstruction (UO,
N = 12) instead of BUO was induced so as not to open the
abdomen and disturb the peritoneal cavity. This procedure was
performed under light halothane anesthesia by placing two
ligatures with 4-0 silk (Davis & Geck, Gosport, UK) around the
external urethra. Sham operation consisted of anesthesia and
manipulation of the external urethra without placing a ligature.
Rats were returned to their cages and food was withheld from
both groups until the time of study, 24 hours later. SOR had
access to water until the time of study, 24 hours later. Rats with
obstructive uropathy were given either L-arginine (1%) in the
drinking water for three days before BUO or UO (Experimental
group) or tap water alone during the same period of time
(Control group).
Induction of puromycin aminonucleoside nephrosis (PAN)
Twenty rats received the aminonucleoside of puromycin (50
mg/kg body weight, i.v.; ICN Biochemicals, Cleveland, Ohio,
USA). Induction of the nephrotic syndrome was validated by
measuring protein in plasma and urine, as previously described
[2]. Blood samples were obtained prior to and 10 days after
administration of puromycin, and kept frozen at —80°C for
determination of plasma levels of urea, creatinine, albumin and
cholesterol and urine concentrations of urea, creatinine and
protein. Analyses of urine were performed in samples obtained
during 24 hour collections, as described previously [2]. Two
groups of rats with PAN were studied. The experimental group
was given tap water with 1% L-arginine from 3 days before to 10
days after administration of puromycin. The control group of
rats with PAN drank tap water alone during the same period of
time.
Standard inulin clearances were performed in 12 SOR, 12 rats
with BUO and in 10 rats with PAN, as described previously
[19]. Briefly, these rats were lightly anesthetized with halothane
and a femoral vein catheter (PE-50), a femoral artery catheter
(PE-lO) and a left ureteral catheter (PE-50, rats with BUO) or a
bladder catheter (Tygon®, rats with PAN) were inserted. The
rats were secured in plastic holders and allowed to awake. After
two hours, for recovery from anesthesia and surgery, a priming
dose of inulin was given in 1 ml of normal saline over a three
minute period, designed to achieve plasma concentrations of
this compound of 50 to 150 mg/dl. Then, a solution containing
inulin in normal saline so as to maintain plasma levels of inulin
constant, was given by constant infusion through the femoral
vein catheter at a rate of 40 zI/min. After one hour of equili-
bration three 20-minute urine collections were obtained and
blood was drawn from the femoral arterial catheter at the
midpoint of each urine collection. Blood samples were centri-
fuged immediately at 3000 rpm for five minutes, hematocrit was
determined and plasma separated for measurements of inulin.
Glomerular isolation and macrophage labeling in
preparations of dissociated cells
These studies were performed in 46 rats (18 SOR, 18 rats with
BUO and 10 rats with PAN). Glomeruli were obtained by
standard sieving techniques [16] and cells dispersed using the
enzymatic dissociation protocol described by Wu, Pippin and
Lefkowith [20]. The yield was between 12 and 14 X i0
glomeruli per rat. Glomeruli were incubated for 20 minutes at
room temperature in 10 ml of HBSS containing collagenase (0.5
mg/mi), trypsin (0.5 mg/ml) and DNAase (0.1 mg/mi; Sigma).
After centrifugation for five minutes at 5,000 rpm, the pellet was
washed three times in HBSS without calcium or magnesium and
incubated for 15 minutes at 37°C with 10 ml of HBSS containing
2 mM EDTA. After washing with HBSS, the pellet was
incubated for 10 minutes at 37°C with 10 ml of HBSS containing
collagenase (1 mg/mI). Subsequently, the preparations were
forced through a 22-gauge needle several times to yield a
single-cell suspension. Basement membrane and debris were
filtered out by passing the cells through siliconized glass wool.
The yield was 5 to 6 x 106 cells from permeabilized glomeruli
per rat, or 400 to 450 cells per glomerulus. At this time, 100 j.d
aliquots of cell suspensions (approximately 5 x io cells/rnl)
were pelleted onto slides by cytocentrifuge (Shandon Inc.,
Pittsburgh, Pennsylvania, USA). The cells were fixed with
methanol:acetone (50:50). Triplicate slides were prepared from
glomeruli obtained from each rat. The number of macrophages
in these preparations was determined by immunohistochemis-
try [21] as follows: after fixation of glomeruli, endogenous
peroxidase activity was suppressed. Preparations were then
sequentially incubated with rabbit serum blocking solution
(Vector Laboratories, Burlingame, California, USA), and with
anti-rat macrophage primary antibody (ED-2), which recog-
nizes specific antigens present in the membrane of macrophages
[21] (Sera Laboratories, Sussex, UK). Negative controls con-
sisted of parallel preparations incubated with comparable dilu-
tions of irrelevant primary antisera. After rinsing, biotinylated
mouse anti-rat IgG (Vector) was added and the slides were
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Table 1. Plasma and urine chemistries in two groups of rats with PAN given tap water containing L-arginine (1%) or tap water alone
N
'Cr
/.Lmol/liter
'Urea
,nmollliter
P&Jb
g/liter
Chol
mmo!/liter
U,,,
ml/24 hr rimo1/24 hr
Uurea
mmol/24 hr
Uprotein
mg/24 hr
PAN + tap water 11 Basal
Final
56 365 5 4.1 0.15.4 0.5 54 318 1 2.7 0.19.4 1.0 15 320 4 663 71429 65 45 426 5 22 4107 19
Paired (-test baseline vs. final NS NS 0.0001 0.0001 NS 0.03 0.007 0.0001
PAN + L-arginine 9 Basal
Final
62 5
64±4
4.4 0.1
8.2±1.0
51 1
17±1
2.6 0.1
10.1±1.1
16 2
23±5
690 62
818±199
42 5
53±8
19 2
95±19
Paired (-test baseline vs. final NS 0.002 0.0001 0.0001 NS NS NS 0.001
Anova between final values NS 0.03 NS NS NS 0.02 0.01 NS
Analyses were performed in plasma and urine samples obtained before (basal values) and 10 days after (final values) administration of puromycin
(50 mg/kg body wt, given i.v.). Abbreviations are: PAN, puromycin aminonucleoside-induced nephrosis; NS, not significantly different; Cr,
plasma concentration of creatinine; PUrea, plasma concentration of urea; PAth, plasma concentration of albumin; PChOI, plasma concentration of
cholesterol; U,,,, urine flow; Ucr, urine excretion of creatinine; Uurea, urine excretion of urea; Uprotein urine excretion of total protein.
incubated with streptavidin peroxidase. Preparations were ex-
posed to diaminobenzidine hydrochloride (Sigma) and counter-
stained with hematoxylin. The positively labeled cells were
quantified in each preparation by light microscopy using a 400x
magnification with an optical micrometer. Leukocyte counts
per glomerulus were multiplied by the total glomerular number
to obtain total leukocyte counts. Assays were performed in
duplicate. This technique correlates well with other methods of
leukocyte quantification [22]. The effect of L-arginine adminis-
tration on the infiltration of the renal parenchyma by macro-
phages was compared to the effect of total body irradiation
(TB!), a maneuver that decreases the infiltration of the kidney
by macrophages [16]. This procedure was performed as de-
scribed previously [16]. Briefly, 72 hours prior to induction of
BUO or sham operation (96 hr prior to studies) the rats were
anesthetized with sodium pentobarbital (50 mg/kg body wt,
Abbott Laboratories, North Chicago, Illinois, USA) and re-
ceived 1032 rads over 10 minutes (Gamma Cell 40, Atomic
Energy of Canada, Ltd), with shielding of the renal area.
Chemotaxis studies
Unstimulated peritoneal macrophages from SOR and from
rats with urethral obstruction were obtained as described by
Mosier [23]. The yield was 15 to 25 x 106 peritoneal cells from
either SOR or rats with urethral obstruction. Thus, there were
no significant differences in cell count between the two groups
of rats. Chemotaxis studies were done using a standard method
[24]. Initial experiments were done with zymosan-activated
serum (ZAS) to determine the concentration that resulted in
maximal migration of macrophages through a filter. ZAS was
obtained by incubating fresh rat serum with 25 mg/ml of
zymosan for 30 minutes at 37°C [25]. The assay (done in
triplicate) was performed as follows: diverse concentrations of
ZAS or L-arginine in D-MEM in 240 d aliquots were placed in
the bottom well of the chemotactic chamber. To the wells in the
upper chamber, 2.5 x 106 macrophages/ml in a volume of 340 jd
of D-MEM were added. The chamber was then incubated at
37°C for two hours in a humidified atmosphere of 95% air with
5% CO2. At this time the filter (Costar-Nucleopore, Pleasanton,
California, USA) separating the upper and lower halves of the
chamber was removed, fixed and stained with hematoxylin.
Cells that had migrated through the filter were quantified by
light microscopy using a 400x magnification and an optical
micrometer. Five fields were counted in each of the three filters.
Results are expressed as the mean number of cells that migrated
through the filter.
Other determinations. Inulin concentrations in plasma and
urine were determined by the anthrone method, as described
[2]. Plasma and urine analyses were performed in samples
obtained from rats given puromycin using the Multistat III Plus
Machine with reagents from Fisher (St. Louis, Missouri, USA).
Total urine protein concentration was determined by the Bio-
Rad assay dye method (BioRad, Richmond, California, USA)
as described [2]. Plasma levels of corticosterone were measured
in ten rats as described [26].
Calculations and statistics
Inulin clearances were calculated using standard formulae.
For each rat the values of three consecutive periods were
averaged. Intragroup comparisons were performed by a paired
t-test. Intergroup comparisons were performed by one way
analysis of variance (ANOVA) with Bonferroni's correction.
Differences were considered significant when P < 0.05.
Results
Validation of induction of the nephrotic syndrome in the rats
given puromycin is provided in Table 1. Ten days after admin-
istration of puromycin, rats drinking either tap water or water
containing L-arginine had significantly greater proteinuria, sig-
nificantly lower plasma albumin levels and significantly greater
plasma cholesterol levels than at baseline. There were no
significant differences in the above measurements between rats
with PAN given L-arginine in the drinking water or tap water
alone. On the other hand, rats with PAN given L-arginine had
significantly higher plasma levels of urea and greater urine
excretion of urea and creatinine after 10 days than at baseline or
than the values obtained after 10 days in rats with PAN given
tap water alone.
The effect of drinking water containing L-arginine (1%)
versus tap water on GFR values is shown in Figure 1 (data are
for one kidney in mi/mm/kg body wt). Normal rats drinking
water with 1% L-arginine for three days prior to study had
significantly greater GFR values (by 26%) than normal rats
drinking tap water alone (7.34 0.5 vs. 5.81 0.3, P < 0.03).
Rats with unilateral release of BUO of 24 hours duration,
drinking water with L-arginine for three days prior to obstruc-
tion had significantly greater GFR values (by 61%) than rats
with unilateral release of BUO drinking tap water (2.87 0.1
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Normal BUO PAN
Fig. 1. Glomerular filtration rate (GFR) in normal rats, rats with
bilateral ureteral obstruction (BUO) and rats with puromycin amino-
nucleoside nephrosis (PAN) given tap water (controls, •) or tap water
supplemented with 1% L-arginine (L-arg, ). Although there was a
significant increase in GFR in normal rats given L-arginine compared to
normal rats drinking tap water alone (controls), there was a greater
percent increase in GFR in rats with BUO or rats with PAN receiving
L-arginine. < 0.03 vs. control value; **< 0.0001 vs. control value;
***D < 0.0001 vs. control value.
vs. 1.78 0.09, P <0.0001). Rats with PAN given water with
L-arginine for 3 days before and 10 days after the administration
of puromycin had significantly greater GFR values (by 133%)
than rats with PAN given water alone for the same period of
time (3.29 0.1 vs. 1.41 0.1, P <0.0001). Although there was
a significant increase in GFR in normal rats given L-arginine,
the data show a greater effect of oral L-arginine administration
on the percent increase in GFR in rats with BUO or rats with
PAN.
We also examined the in vivo effect of L-arginine administra-
tion on the infiltration of glomeruli by macrophages. Glomeruli
from normal rats drinking water, or water with L-arginine or
undergoing total body irradiation had a negligible population of
cells that stained as macrophages (0 to 1 macrophages/100
glomeruli). The number of macrophages per 100 glomeruli for
rats with BUO or PAN, is depicted in Figure 2. Figure 2A
shows that rats drinking water alone for three days prior to
BUO had a greater number of macrophages (283 22) than rats
with BUO drinking water with L-arginine for the same period of
time (79 9, P < 0.0001) or than rats that had total body
irradiation prior to BUO (31 1, P < 0.0001). Administration of
L-arginine decreased the macrophage infiltration of glomeruli
by over 70% but this effect was less (P < 0.0001) than the 90%
depletion seen after total body irradiation, a maneuver that
depletes the kidney of resident interstitial macrophages and
inhibits the influx of macrophages in rats with BUO [16, 27].
Figure 2B shows that rats with PAN given L-arginine in the
drinking water for 3 days before and 10 days after the admin-
istration of puromycin had a lesser number of infiltrating
macrophages (365 296) than rats with PAN drinking water
alone during the same period of time (13899 2941, P <
0.0001). This value is also significantly greater than the one
obtained in glomeruli from control rats (0 to 1 macrophage/100
glomeruli, P < 0.0001). These results suggest that the beneficial
effect of oral administration of L-arginine on renal function of
rats with BUO or PAN may be due, at least in part, to a
significant decrease in the number of macrophages infiltrating
the renal parenchyma.
The lower counts of macrophages detected by immunohisto-
chemistry in the three groups of normal rats may be due to the
use of the ED-2 anti-macrophage antibody which selectively
recognizes tissue macrophages but not its precursors. Previ-
ously reported measurements of the macrophage population,
including those from this laboratory, were performed in forma-
lin-fixed preparations of perfused kidneys using ED-i antibod-
ies recognizing not only tissue macrophages but also the pre-
cursors, mononuclear cells and circulating leukocytes. Thus,
the current results may more accurately describe the number of
resident macrophages present in the normal kidney.
The intrinsic chemokinetic capacity of peritoneal macro-
phages isolated from SOR or rats with urethral obstruction was
examined. Figure 3A shows that migration (values are given as
mean number of cells/400 x field) of macrophages obtained from
rats with sham urethral obstruction and incubated with 0% ZAS
was significantly less than with 7% ZAS (24 3 vs. 308 17,
P < 0.0001). Random migration of macrophages isolated from
rats with urethral obstruction of 24 hours duration was signifi-
cantly greater than that of macrophages obtained from rats with
sham-urethral obstruction (272 15 vs. 24 3, P < 0.0001; Fig.
3B). Seven percent ZAS induced maximal chemotaxis of the
cells from rats with urethral obstruction (367 10) at a level
significantly greater (P < 0.0001) than that observed in macro-
phages isolated from rats with sham urethral obstruction (308
17). These data suggest that peritoneal macrophages were
activated during obstruction, as manifested by increased ran-
dom kinesis.
After establishing 7% ZAS as the concentration for maximal
chemotaxis, the effect of different concentrations of L-arginine
on the capacity of macrophages to migrate in response to 7%
ZAS was tested. Figure 4A shows that peritoneal macrophages
from rats with sham urethral obstruction incubated with differ-
ent concentrations of L-arginine had a biphasic response to 7%
ZAS. Cells incubated with low concentrations of L-arginine and
7% ZAS had increased chemotaxis over the values obtained
with 7% ZAS alone: with 10—6 M L-arginine the value was 289
29 and with iO- M L-arginine the value was 308 18 (P <
0.0001 when either value is compared to the value obtained with
7% ZAS alone, 226 20). With io M L-arginine the chemo-
taxis value (245 13) was not significantly different from that
observed with 7% ZAS alone. Chemotaxis decreased signifi-
cantly with concentrations of L-arginine similar to those in
normal renal tissue: with l0 M L-arginine the value was 170
8 (P < 0.03 when this value is compared to that found with ZAS
alone). Concentrations of L-arginine greater than those in
normal tissue (l0_2 M) further decreased chemotaxis (95 5;
P < 0.0001 compared to the value with 7% ZAS alone). Figure
4B shows the effects of L-arginine on chemotaxis of peritoneal
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Fig. 2. Quantification of glomerular
macrophages in rats with bilateral ureteral
obstruction (A, BUO) or puromycin
aminonucleoside nephrosis (B, PAN) given
tap water (controls) or subjected to total
body irradiation (TB!) or given L-arginine
(L-arg) in the drinking water. *p < 0.0001
vs. control value.
macrophages obtained from rats with urethral obstruction.
Again, kinesis of macrophages from rats with urethral obstruc-
tion of 24 hours duration was significantly greater than that of
macrophages from non-obstructed rats (355 8 vs. 18 2, P <
0.0001), suggesting activation of these cells during obstruction.
This value was further increased by incubation with 7% ZAS
(401 13, P < 0.0001). Incubation of macrophages with
L-arginine in the iO— to 10—2 M range, but not in the 10_6 M to
l0— M range, resulted in significant reduction of chemotaxis in
response to 7% ZAS. As noted above, 10 M is the concen-
tration of L-arginine in normal renal tissue in the rat [281.
We also tested the migration of peritoneal macrophages from
rats with sham urethral obstruction in response to L-arginine, in
Fig. 4. Migratory response of peritoneal
macrophages isolated from rats with
urethral obstruction of 24 hours duration
or sham operation to 7% zymosan-
activated serum (ZAS) with or without L-
arginine (L-arg) in the drinking water.
*significantly different (P < 0.02) from
values representing stimulation with 7%
— 6 5 4 3 2 ZAS (second column). **significantly
different (P < 0.05) from random migration
Urethral obstruction values (first column).
the absence of ZAS. Figure 5 shows a bell-shaped response of
peritoneal macrophages to L-arginine. There was an increased
macrophage migration at low concentrations of L-arginine
(10 to iO M) with the greatest chemotactic response occur-
ring at 106 M L-arginine (72 3, P < 0.0001 vs. random
migration). However, this maximal value was only 35% of the
one found in response to 7% ZAS (209 13, P < 0.0001 vs.
migration obtained by adding 106 M L-arginine). Higher con-
centrations of L-arginine in the media (l0— M and 10_2 M) did
not significantly affect migration of these cells (14 2 and 11
2, respectively) when compared to migration into media alone
(9 1). This lack of difference in macrophage chemotaxis from
media alone at higher concentrations of L-arginine may be due
a)
E0
0)001
C,)
ciC)
0.00
A
*
*
I I
Control +TBI +L-arg
Rats with BUO
A
*
400
320
240
160
80
0
400
300
200
100
0
* * *nnn
0 3 5 7 10 20 50
ZAS, %
Sham urethral obstruction
Fig. 3. Migratory response of peritoneal
macrophages isolated from rats with
urethral obstruction of 24 hours duration
or sham operation to zymosan-activated
serum (ZAS). *Significantly different (P <
0.0001) from values representing
incubation without ZAS (first column, Fig.
3A). **Signjficantly different (P < 0.003)
from values representing incubation
without ZAS (first column, Fig. 3B).
A
4000
300
Cl)
200
110:
7% ZAS — + + + + + +
—Log [L-argj M — — 6 5 4 3 2
Sham urethral obstruction
—Log [L-arg] M —
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to rapid equilibration of the gradient between the upper and
lower halves of the chemotactic chamber.
A second interpretation is the occurrence of a different
response of macrophages to L-arginine, with lower concentra-
tions stimulating migration and greater concentrations of L-ar-
ginine inhibiting migration. To test this possibility we incubated
macrophages obtained from three normal rats with different
concentrations of L-arginine at 37°C for 30 minutes. After
incubation, the cells were washed with HBSS and random
migration was examined. Simultaneously, peritoneal macro-
phages obtained from the same rats were incubated either in
media alone at 37°C for 30 minutes or with 7% ZAS. Subse-
quently, cells were also washed in HBSS. The results of these
experiments are depicted in Figure 6. Peritoneal macrophages
pre-incubated with low concentrations of L-arginine (10—8 to
iO M) had significantly greater random migration than mac-
rophages pre-incubated with media alone. The greatest random
migration occurred with pre-incubation at i0 M L-arginine
(111 6 vs. 12 6, P < 0.00001). Incubation of cells with
greater concentrations of L-arginine (l0— and 102 M) resulted
in values for random migration not significantly different from
those obtained for peritoneal macrophages pre-incubated with
media alone. The increase in random migration of peritoneal
macrophages pre-incubated with l0 M L-arginine was signif-
icantly less than that obtained with 7% ZAS (111 6 vs. 129
11, P < 0.03).
The finding of a greater migration of macrophages obtained
from rats with urethral obstruction (Figs. 3 and 4) allowed us to
test the hypothesis that administration of L-arginine in vivo
may have immunosuppressive effects. Rats with urethral ob-
struction were given tap water with 1% L-arginine (N = 2) or
tap water alone (N = 2) for three days before obstruction. SOR(N = 2) were given tap water. Peritoneal macrophages were
obtained from these rats 24 hours after obstruction or sham
operation and used to assess random migration and migration in
response to 7% ZAS. The results of these experiments are
depicted in Figure 7. Random migration of peritoneal macro-
FIg. 6. Random migration of peritoneal macrophages isolated from
rats with sham urethral obstruction of 24 hours duration and pre-
incubated with L-arginine at 37°C for 30 minutes. After incubation,
cells were washed in media and random migration was determined.
Pre-incubation of macrophages with low concentrations of L-arginine
per se (108 to iO M), in the absence of any chemotactic stimulus,
significantly increased the migratory capability of these cells. *p <
0.0001 vs. random migration (M).
phages obtained from SOR was significantly lower (9 2) than
alter incubation with 7% ZAS (228 13, P < 0.0001). Random
migration of peritoneal macrophages obtained from rats with
urethral obstruction given tap water was significantly greater
than that of peritoneal macrophages obtained from SOR (241
16 vs. 9 2, P < 0.0001). Incubation with 7% ZAS resulted in
a significant increase in migration (311 22 vs. 241 16, P <
0.005). In contrast, peritoneal macrophages obtained from rats
with urethral obstruction given tap water with L-arginine for
three days prior to obstruction had a random migration that was
significantly lower than that observed in peritoneal macro-
phages obtained from rats given tap water during the same
period of time (43 7 vs. 241 16, P < 0.0001). Thus,
administration of L-arginine in vivo decreases macrophage
migration in vitro.
Barbul et al [29] reported that the significant increase in
tensile strength in the rat model of wound healing observed
alter giving L-arginine was not present in rats with hypophy-
sectomy, suggesting that in this model the effect of L-arginine
administration may be hormone-mediated. We designed exper-
iments to determine the effect of giving the animals tap water
with L-arginine (N = 5) or tap water alone (N = 5) during three
days prior to BUO on the plasma levels of corticosterone.
Plasma samples were obtained prior to and 24 hours alter BUO.
Figure 8 shows that rats given L-arginine prior to BUO had
plasma levels of corticosterone significantly greater 24 hours
after surgery than before surgery (7.10 0.73 g/dl vs. 11.42
1.13 g/dl, P < 0.002). In contrast, no significant changes in
plasma levels of corticosterone were observed in the rats given
tap water alone prior to BUO (7.40 0.35 vs. 7.48 0.88).
Discussion
We found that L-arginine ameliorates the infiltration of the
renal parenchyma by macrophages in rats with obstructive
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Fig. 5. Migratory response of peritoneal macrophages isolated from
rats with sham urethral obstruction of 24 hours duration to different
concentrations of L-arginine. Low concentrations of L-arginine per se
(l0— to l0— M), in the absence of any chemotactic stimulus, signifi-
cantly increased the migratory capability of peritoneal macrophages.
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Fig. 7. Effect of oral administration of L-arginine in the drinking water
(1%) during the three-day period prior to urethral obstruction (•) on
random migration (M) and migration in response to zymosan-activated
serum (ZAS) of peritoneal macrophages obtained from rats with
urethral obstruction of 24 hours duration. Peritoneal macrophages
obtained from rats given L-arginine in the drinking water during the
three day period prior to urethral obstruction () had significantly
lower random migration and ZAS-stimulated migration than macro-
phages obtained from rats given tap water alone prior to urethral
obstruction (0). The values for peritoneal macrophages obtained from
sham-operated rats (SOR) are also shown. *D < 0.0001 vs. random
migration (M) of peritoneal macrophages from sham-operated rats(SOR) and of rats given tap water alone during the three day period
prior to urethral obstruction.
nephropathy and in rats with puromycin-induced nephrotic
syndrome. This effect of L-arginine may be due to several
factors including a decrease in the intrinsic capacity of macro-
phages to migrate when exposed to L-arginine and/or increased
release of endogenous corticosterone after administration of
L-arginine in vivo.
Administration of L-arginine to rats before induction of BUO
or before and during PAN resulted in values of GFR that were
61 and 133% greater than the values obtained in similar rats not
given L-arginine. Normal rats given L-arginine in the drinking
water also had a significant increase in GFR (by 26%) when
compared to normal rats given tap water alone. From these
results it is unclear if the greater GFR values seen in rats with
BUO or PAN drinking L-arginine were due to hemodynami-
cally mediated factors, as seen in normal rats (Fig. 1), or to an
unrelated mechanism. Immunohistochemistry studies using a
monoclonal antibody that recognizes tissue macrophages, but
not mononuclear cells [21, 30], demonstrated that the infiltra-
tion of glomeruli by macrophages in rats with BUO of 24 hours
duration was markedly reduced, to about 10% of controls, by
total body irradiation, a maneuver that effectively inhibits bone
marrow production of mononuclear cells. Administration of
L-arginine prior to BUO was also effective in reducing that
infiltration (to about 30% of controls; Fig. 2A). Thus, in vivo
L-arginine administration in the drinking water markedly and
3
0
Fig. 8. Plasma levels of corticosterone in rats given or not given
L-arginine prior to induction of bilateral ureteral obstruction (BUO).
Rats given L-arginine prior to BUO had plasma levels of corticosterone
significantly greater 24 hours after surgery () than at baseline (0). In
contrast, no significant changes in plasma levels of corticosterone were
observed in the rats given tap water alone prior to BUO. *R < 0.002 vs.
basal value.
significantly decreased the macrophage infiltration of the renal
parenchyma in rats with BUO. Likewise, the macrophage
infiltration of the kidney in rats with puromycin-induced ne-
phrotic syndrome was markedly and significantly reduced by
the administration of L-arginine in the drinking water (Fig. 2B).
No comparisons of the effect of total body irradiation versus
L-arginine administration on infiltration of macrophages in
PAN rats was possible since rats do not survive total body
irradiation for periods greater than six or eight days.
We found that macrophages obtained from rats with urethral
obstruction of 24 hours duration exhibited significantly greater
random migration than those obtained from SOR (Fig. 3). The
finding of significantly greater migration of peritoneal macro-
phages obtained from rats with urethral obstruction indicates
that macrophages became activated during obstruction as man-
ifested by increased chemokinesis. Our results do not allow us
to exclude the possibility that macrophages from rats with
urethral obstruction were "primed" by an endogenous
chemoattractant during the 24-hour period of obstruction [31],
and that as a result they exhibited significantly greater migra-
tion.
We also found in in vitro experiments an increased migration
of peritoneal macrophages towards 7% ZAS when incubated
with low concentrations of L-arginine (10 M) and decreased
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migration of these cells when incubated with high concentra-
tions of L-arginine (10—i to 102 M). Thus, low concentrations
of L-arginine are chemoattractant to peritoneal macrophages.
The decreased chemotaxis of macrophages after incubation
with greater concentrations of L-arginine may be due, in part,
to rapid dissipation of the gradient between the two halves of
the chemotactic chamber.
To examine in more detail the potential effect of L-arginine
on macrophage migration, we conducted additional experi-
ments in vitro and in vivo.
Concentrations of L-arginine of 10_6 to i0 M significantly
enhanced and concentrations of L-arginine of 10 to l0_2 M
significantly decreased the chemotactic response of peritoneal
macrophages isolated from SOR to 7% ZAS (Fig. 4A). These
experiments suggest that the intrinsic capability of macro-
phages to migrate in response to a chemoattractant stimuli is
enhanced by low concentrations of L-arginine. This observa-
tion may be relevant in vivo in view of the potential existence of
a chemotactic agent of renal origin in rats with obstructive
nephropathy [31].
Experiments utilizing different concentrations of L-arginine
(Fig. 5) demonstrated that L-arginine per se, in the absence of
a chemoattractant, changes the chemotactic properties of mac-
rophages. This suggests that changes in the concentrations of
this amino acid at the cellular and/or tissue level may play a key
role in the migratory response of macrophages. The chemotac-
tic activity of macrophages appears to be enhanced at low
L-arginine concentrations (less than 100 M) and depressed in a
high L-arginine environment (more than 100 sM). Thus, levels
of L-arginine in plasma and tissues may be of pivotal impor-
tance in modulating macrophage migration into tissues and/or
organs sustaining an immune-mediated lesion. To further define
the effects of L-arginine on macrophage migration we pre-
incubated these cells with different concentrations of L-argi-
nine. After preincubation the macrophages were washed to
remove L-argmine and the migration of these cells was exam-
ined. We found (Fig. 6) that pre-incubation with L-arginine in
the i04 to iO M range significantly increased migration of
peritoneal macrophages. Furthermore, pre-incubation of pen-
toneal macrophages with concentrations of L-arginine in the
10_2 to iO M range did not result in significant changes in the
migration of these cells.
Peritoneal macrophages obtained from rats with urethral
obstruction exhibited significantly greater random migration
than macrophages obtained from SOR. Interestingly, this effect
was blunted by administration of 1% L-arginine in the drinking
water to rats with urethral obstruction for three days prior to
obstruction. This observation strongly suggests that L-arginine
affects directly the chemotaxis or chemokinesis of macrophages
(Fig. 7).
Our results are in agreement with the observations of Albina
et al [6, 32, 33], who reported that peritoneal macrophages
cultured in a low L-arginine medium (less than 100 jsM) had
greater cytotoxicity against tumor cells, greater superoxide
production and phagocytosis and that these functions were
suppressed in macrophages incubated with increasing concen-
trations of L-arginine. Thus, L-arginine may be considered a
natural inhibitor of macrophage functions at concentrations
similar to those found in normal renal tissue in the rat.
We found greater levels of plasma corticosterone in rats given
L-arginine prior to BUO. Thus, L-arginine may modulate
macrophage action in vivo, at least in part, by increasing release
of endogenous steroids with known anti-inflammatory proper-
ties. This interpretation is reminiscent of the reports of Barbul
et al in a rat model of wound healing [29], a macrophage-
dependent process [34]. These investigators found significantly
greater tensile strength in wounds of rats given L-arginine in the
drinking water than in wounds obtained from control rats given
water alone. The effect of L-arginine on wound healing was
absent in hypophysectomized rats, suggesting that, in vivo,
L-arginine mediated synthesis/release of a hormone from the
pituitary gland. Taken together, these studies and results sug-
gest that the beneficial effect of oral administration of L-argi-
nine on immune cell-mediated renal disease may be mediated,
at least in part, by the increased release of endogenous steroids.
However, there is also an intrinsic effect of L-arginine to inhibit
macrophage function at concentrations normally found in
plasma or renal tissue.
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